- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07615244
STUDY OF MICROVASCULAR DAMAGE IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA (MITHO)
The goal of this interventional, non-pharmacological clinical study is to assess microcirculatory dysfunction in patients with thrombotic thrombocytopenic purpura (TTP), both during the acute phase and in remission, compared with the general population.
Microcirculatory damage will be defined as the presence of at least one abnormal instrumental finding among brain magnetic resonance imaging (MRI), optical coherence tomography angiography (OCT-A), and nailfold videocapillaroscopy.
This is a monocentric, national study including two patient cohorts:
Cohort 1: patients enrolled during the acute phase Cohort 2: patients enrolled during remission Participants will be followed for three years with a total of five study visits.
Researchers will not test any drug but will perform detailed clinical, laboratory, and instrumental assessments to evaluate microvascular involvement over time.
Participants will:
- Undergo clinical evaluation, including internal medicine and neurological assessments
- Provide blood and urine samples for laboratory analyses
- Undergo instrumental examinations such as brain MRI, OCT-A, and nailfold videocapillaroscopy
- Receive psychological/neuropsychological evaluations
- Attend follow-up visits over a 3-year period (at baseline, 3 months [cohort 1 only], 12, 24, and 36 months)
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
- Test diagnostico: Factor VIII (FVIII)
- Test diagnostico: Von Willebrand factor (VWF) antigen
- Test diagnostico: VWF:RCo
- Test diagnostico: VWF-propeptide
- Test diagnostico: VWF multimers
- Test diagnostico: sP-selectin
- Test diagnostico: sCD40L
- Test diagnostico: F1+2
- Test diagnostico: VEGF-A
- Test diagnostico: VCAM
- Test diagnostico: ICAM
- Test diagnostico: IL-1β
- Test diagnostico: IL-6
- Test diagnostico: PTX3
- Test diagnostico: BlyS
- Test diagnostico: Neutrophil elastase and myeloperoxidase (NETs) markers
- Test diagnostico: soluble C5b-9
- Test diagnostico: C5a
- Test diagnostico: NFL
- Test diagnostico: GFAP
- Genetico: Whole exome sequencing - WES
- Test diagnostico: Proteomic Analysis
- Test diagnostico: evaluation of thrombus formation with Total Thrombus formation Analysis System (T-TAS)
- Test diagnostico: Microfluidic Flow Chamber
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Milano
-
Milan, Milano, Italia, 20122
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Adulto
- Adulto più anziano
Accetta volontari sani
Descrizione
Inclusion Criteria:
- aged ≥18 years
- with a confirmed diagnosis of TTP (either congenital or acquired immune-mediated TTP)
- referred at our hospital (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico) in acute phase of a first or recurrent episode (cohort 1) or referred at our outpatient clinic (S.C. Medicina - Emostasi e Trombosi) during clinical remission at more than 3 months from the clinical response of the previous episode (cohort 2). In any case, patient enrolment will always take place in the S.C. Medicina - Emostasi e Trombosi
- providing a signed informed consent
Exclusion Criteria:
- Patients who do not possess the above inclusion criteria or have known contraindications to the instrumental exam included in the study (MRI).
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Diagnostico
- Assegnazione: Non randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Altro: Acute TTP
Patients enrolled during acute phase (cohort 1), T0= within 15 days from hospital admission.
|
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
|
|
Altro: Remission TTP
Patients enrolled during clinical remission (cohort 2), T0= check-up visit performed at more than 3 months from clinical response of the previous episode
|
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Prevalence
Lasso di tempo: From enrollment to the last visit (after 36 months from T0)
|
Prevalence of microcirculation damage in iTTP patients compared to general population
|
From enrollment to the last visit (after 36 months from T0)
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Cerebral microcirculation lesions
Lasso di tempo: From enrollment to the last visit (after 36 months from T0)
|
Evaluate cerebral microcirculation lesions (via brain MRI) in both acute and remission phases of TTP to monitor organ damage progression over time
|
From enrollment to the last visit (after 36 months from T0)
|
|
Retinal microcirculation changes
Lasso di tempo: From enrollment to the last visit (after 36 months from T0)
|
Assess retinal microcirculation changes (using OCT and OCT-A) during acute and remission phases of TTP to track organ damage evolution
|
From enrollment to the last visit (after 36 months from T0)
|
|
Peripheral microcirculation
Lasso di tempo: From enrollment to the last visit (after 36 months from T0)
|
Analyze peripheral microcirculation (with nailfold videocapillaroscopy) in acute and remission phases to evaluate progression of organ involvement in TTP
|
From enrollment to the last visit (after 36 months from T0)
|
|
Association between cerebral MRI lesions and cognitive or psychological symptoms
Lasso di tempo: From enrollment to the last visit (36 months from T0)
|
Explore the relationship between cerebral MRI lesions and cognitive or psychological symptoms during TTP remission, assessing symptom progression
|
From enrollment to the last visit (36 months from T0)
|
|
Modification of preclinical biomarkers
Lasso di tempo: From enrollment to the last visit (36 months from T0)
|
Explore the modification of preclinical biomarkers over time at different stage of the disease
|
From enrollment to the last visit (36 months from T0)
|
|
Associations between preclinical biomarkers and microcirculatory damage
Lasso di tempo: From enrollment to the last visit (36 months from T0)
|
Identify associations between preclinical biomarkers and microcirculatory damage in both acute and remission phases of TTP to predict risk and progression
|
From enrollment to the last visit (36 months from T0)
|
Collaboratori e investigatori
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
- Citopenia
- Processi patologici
- Emorragia
- Manifestazioni cutanee
- Malattie ematologiche
- Disturbi della coagulazione del sangue
- Disturbi delle piastrine del sangue
- Microangiopatie trombotiche
- Porpora, Trombocitopenica
- Porpora
- Trombocitopenia
- Trombofilia
- Condizioni patologiche, segni e sintomi
- Segni e sintomi
- Malattie emiche e linfatiche
- Porpora, Trombotico Trombocitopenico
- Tecniche investigative
- Tecniche genetiche
- Analisi di sequenza
- Analisi della sequenza, DNA
- Sequenziamento dell'intero genoma
- Sequenziamento dell'esoma
Altri numeri di identificazione dello studio
- IRCCSMaggioreH (IRCCSMaggioreH)
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Factor VIII (FVIII)
-
BayerCompletato
-
Hoffmann-La RocheChugai PharmaceuticalCompletatoEmofilia AAustralia, Taiwan, Corea, Repubblica di, Francia, Germania, Italia, Sud Africa, Spagna, Stati Uniti, Giappone, Irlanda, Polonia, Regno Unito, Costa Rica
-
Hospices Civils de LyonTerminato
-
Grifols Biologicals, LLCAttivo, non reclutanteMalattia di Von Willebrand
-
Fondazione Angelo Bianchi BonomiSintesi Research SrlCompletatoEmofilia AStati Uniti, India, Spagna, Argentina, Austria, Brasile, Chile, Egitto, Iran (Repubblica Islamica del, Italia, Messico, Arabia Saudita, Sud Africa, Tacchino
-
Federico II UniversityCompletato
-
Dhaka Medical CollegeNon ancora reclutamento
-
Chulalongkorn UniversityCompletato